Ethics roundtable: Using new, expensive drugs
Costly genetically engineered therapies, which threaten to cripple the health care industry economy and undermine the common good if applied indiscriminately, loom on the horizon. The spectrum of applicable candidates include moribund nursing home patients at the end of life. They will be fair game...
Salvato in:
| Pubblicato in: | Crit Care |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2002
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC153428/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12493067/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1533 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|